Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 4, 1998, Pages 338-340

  Gruber, Michael L ^a   Glass, Jon ^a   Choudhri, Haroon ^a   Nirenberg, Anita ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Carboplatin; Drug therapy; Glioblastoma multiforme; Radiotherapy

Indexed keywords

CARBOPLATIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CRANIAL IRRADIATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0031818560     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199808000-00004     Document Type: Article

References (13)

1. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy and nitrosureas in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978;49:333-43.
2. Walker MD, Green SP, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
3. Fine HA, Dear KB, Loeffler JS, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-97.
4. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215-28.
5. Walker RW. Carboplatin (CBDCA) in the treatment of recurrent glioma. Neurology 1988;38:390-1.
6. Warnick RE, Prados MD, Mack EE, et al. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neurooncol 1994;19:69-74.
7. Yung WKA, Mechtler L, Gleason MJ. Intravenous carboplatin for recurrent malignant glioma: a phase II study. J Clin Oncol 1991;9:860-4.
8. Poisson M, Péréon Y, Chiras J, et al. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA). J Neurooncol 1991;10:139-44.
9. Macdonald DR, Cascino TL, Schold SC Jr, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80.
10. Qin D, Ma J, Xiao J, Tang Z. Effect of brain irradiation on blood-CSF barrier permeability of chemotherapeutic agents. Am J Clin Oncol 1997;20:263-4.
11. Kim L, Hochberg FH, Thornton AF, et al. Procarbazine, lomustine and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg 1996;85:602-7.
12. Glass J, Gruber ML, Cher L, et al. Pre-irradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994;81:188-95.
13. Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 1988;6:338-43.